Cetraxate (INN) is an oral gastrointestinal medication which has a cytoprotective effect.

The latter is a hemostatic agent because it inhibits the activation of plasminogen to plasmin.

The result is to prevent excess loss of blood in gastrointestinal ulcers.

The synthesis begins with the esterification of 3-(p-hydroxyphenyl)propionic acid (2) by trans-4-cyanocyclohexanecarbonyl chloride (1).

[3][4] This drug article relating to the gastrointestinal system is a stub.